Company intelligence / Profile preview

Rex Bionics

London, England, United Kingdomrexbionics.com ↗

Ownership: Private
Development stage: Other

Overview

The REX exoskeleton enables hands-free functional exercise and activities of daily living for people with severe disabilities. It allows autonomous control within minutes of first use. Clinical feedback highlights benefits such as reduced spasms and improved quality of life. The system supports structured exercise programs directed by healthcare professionals

Therapeutic areas: NeurologyOther
Modalities: Device
Industry: Assistive Medical Devices

Partnerships

No major pharmaceutical or biotech partnerships identified in public sources.

Beyond the preview

Go deeper on Rex Bionics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rex Bionics.

Explore the full profile